INSIGHTS AND PERSPECTIVES

RALEIGH, N.C. — A regional retail pharmacy chain and a nearby school of pharmacy will collaborate on a study to evaluate the implementation of a pharmacogenetic program in a community pharmacy setting.

Kerr Drug announced Friday that it would work with the University of North Carolina Chapel Hill's Eshelman School of Pharmacy to explore the feasibility of a program for Sanofi's and Bristol-Myers Squibb's blood-thinning drug Plavix (clopidogrel bisulfate).

MCLEAN, Va. — Consumer packaged goods brands that dedicate a share of their overall marketing resources to the ever-growing Hispanic market prompted about one-third of their overall revenue growth, according to a study from the Association of Hispanic Advertising Agencies.

WASHINGTON — Prices for generic drugs may be dropping, but increases in branded and specialty drug prices have offset those decreases, according to a new study.

The study, conducted by AARP's Public Policy Institute, found that the cumulative change in drug prices from 2005 to 2009 was almost double the rate of inflation. As a result, the average annual cost of drug therapy continued to rise.

NEW YORK — A drug under development by Forest Labs and Pierre Fabre "significantly" reduced symptoms of major depressive disorder, the companies said Wednesday.

New York-based Forest and Paris-based Pierre Fabre announced results of a phase-3 trial of levomilnacipran, saying the drug showed reductions in symptoms as early as one week after treatment was started. The companies expect results of another phase-3 trial of the drug this spring.

MINNEAPOLIS — Kantar Media on Wednesday reported that overall retailer advertising expenditures increased 1.6% and retailer participation in Free Standing Insert coupon promotion pages increased 30.7% over calendar year 2011, versus the corresponding year-ago period. Additionally, digital coupon events increased 40.4% during this period across the leading retailer websites monitored by Kantar Media.

TORONTO — Patients in Canada increasingly are tapping into the healthcare knowledge, expertise and services available at their local pharmacy, with many of them talking to their pharmacist about one or more healthcare issues other than filling a prescription, according to the findings of a new Nielsen survey commissioned by the Canadian Association of Chain Drug Stores.

JERUSALEM — A drug under development by Teva Pharmaceutical Industries appears safe and effective in treating allergies, according to results of a late-stage clinical trial released Monday.

Teva said a 529-patient phase-3 trial of Qnasl (beclomethasone dipropionate) nasal aerosol showed the drug produced a "significant" improvement in patients with seasonal and perennial allergies. Patients received either 320 mcg of Qnasl or a placebo.

WHAT IT MEANS AND WHY IT'S IMPORTANT — The highest circulation of any health magazine in America. That's a major commitment when you think how hard consumer magazines have been hit in recent years.

(THE NEWS: Sam's Club launches wellness magazine for members. For the full story, click here)